TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

MLA

Meijer, A. J. M., et al. “TCERG1L Allelic Variation Is Associated with Cisplatin-Induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study.” Meijer , A J M , Diepstraten , F A , Langer , T , Broer , L , Domingo , I K , Clemens , E , Uitterlinden , A G , de Vries , A C H , van Grotel , M , Vermeij , W P , Ozinga , R A , Binder , H , Byrne , J , van Dulmen-Den Broeder , E , Garrè , M L , Grabow , D , Kaatsch , P , Kaiser , M , Kenborg , L , Winther , J F , Rechnitzer , C , Hasle , H , Kepak , T , Kepakova , K , Tissing , W J E , van Der Kooi , A L F , Kremer , L C M , Kruseova , J , Pluijm , S M F , Kuehni , C E , van Der Pal , H J H , Parfitt , R , Spix , C , Tillmanns , A , Deuster , D , Matulat , P , Calaminus , G , Hoetink , A E , Elsner , S , Gebauer , J , Haupt , R , Lackner , H , Blattmann , C , Neggers , S J C M M , Rassekh , S R , Wright , G E B , Brooks , B , Nagtegaal , A P , Drögemöller , B I , Ross , C J D , the PanCareLIFE Consortium & and the CPNDS Consortium 2021 , ’ TCERG1L Allelic Variation Is Associated with Cisplatin-Induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study ’ , Npj Precision Oncology , Vol. 5 , 64 , 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322768171&authtype=sso&custid=ns315887.

APA

Meijer, A. J. M., Diepstraten, F. A., Langer, T., Broer, L., Domingo, I. K., Clemens, E., Uitterlinden, A. G., de Vries, A. C. H., van Grotel, M., Vermeij, W. P., Ozinga, R. A., Binder, H., Byrne, J., van Dulmen-den Broeder, E., Garrè, M. L., Grabow, D., Kaatsch, P., Kaiser, M., Kenborg, L., … Ross, C. J. D. (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. Meijer , A J M , Diepstraten , F A , Langer , T , Broer , L , Domingo , I K , Clemens , E , Uitterlinden , A G , de Vries , A C H , van Grotel , M , Vermeij , W P , Ozinga , R A , Binder , H , Byrne , J , van Dulmen-Den Broeder , E , Garrè , M L , Grabow , D , Kaatsch , P , Kaiser , M , Kenborg , L , Winther , J F , Rechnitzer , C , Hasle , H , Kepak , T , Kepakova , K , Tissing , W J E , van Der Kooi , A L F , Kremer , L C M , Kruseova , J , Pluijm , S M F , Kuehni , C E , van Der Pal , H J H , Parfitt , R , Spix , C , Tillmanns , A , Deuster , D , Matulat , P , Calaminus , G , Hoetink , A E , Elsner , S , Gebauer , J , Haupt , R , Lackner , H , Blattmann , C , Neggers , S J C M M , Rassekh , S R , Wright , G E B , Brooks , B , Nagtegaal , A P , Drögemöller , B I , Ross , C J D , the PanCareLIFE Consortium & and the CPNDS Consortium 2021 , ’ TCERG1L Allelic Variation Is Associated with Cisplatin-Induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study ’ , Npj Precision Oncology , Vol. 5 , 64 .

Chicago

Meijer, A. J.M., F. A. Diepstraten, T. Langer, L. Broer, I. K. Domingo, E. Clemens, A. G. Uitterlinden, et al. 2021. “TCERG1L Allelic Variation Is Associated with Cisplatin-Induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study.” Meijer , A J M , Diepstraten , F A , Langer , T , Broer , L , Domingo , I K , Clemens , E , Uitterlinden , A G , de Vries , A C H , van Grotel , M , Vermeij , W P , Ozinga , R A , Binder , H , Byrne , J , van Dulmen-Den Broeder , E , Garrè , M L , Grabow , D , Kaatsch , P , Kaiser , M , Kenborg , L , Winther , J F , Rechnitzer , C , Hasle , H , Kepak , T , Kepakova , K , Tissing , W J E , van Der Kooi , A L F , Kremer , L C M , Kruseova , J , Pluijm , S M F , Kuehni , C E , van Der Pal , H J H , Parfitt , R , Spix , C , Tillmanns , A , Deuster , D , Matulat , P , Calaminus , G , Hoetink , A E , Elsner , S , Gebauer , J , Haupt , R , Lackner , H , Blattmann , C , Neggers , S J C M M , Rassekh , S R , Wright , G E B , Brooks , B , Nagtegaal , A P , Drögemöller , B I , Ross , C J D , the PanCareLIFE Consortium & and the CPNDS Consortium 2021 , ’ TCERG1L Allelic Variation Is Associated with Cisplatin-Induced Hearing Loss in Childhood Cancer, a PanCareLIFE Study ’ , Npj Precision Oncology , Vol. 5 , 64 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322768171&authtype=sso&custid=ns315887.